Literature DB >> 9771971

The activation and composition of FiRE (an FGF-inducible response element) differ in a cell type- and growth factor-specific manner.

P Jaakkola1, A Määttä, M Jalkanen.   

Abstract

The expression of the heparan sulfate proteoglycan, syndecan-1, is induced both in keratinocytes and in fibroblasts during development and tissue regeneration. Here we report that in keratinocytes the syndecan-1 gene was stimulated by EGF but not by FGF-2. In fibroblasts it was stimulated by FGF-2 but not by EGF. Likewise, the recently discovered FGF-inducible response element (FiRE) on the gene of syndecan-1 was stimulated by FGF-2 in fibroblasts and by EGF in keratinocytes, but not vice versa. The FiRE has two binding sites for an activator protein-1 (AP-1), one for an FGF-inducible nuclear factor (FIN-1) and one for an upstream stimulatory factor-1 (USF-1). The growth factor-stimulated binding of these transcription factors, as well as their requirement for FiRE activation, varied between the two cell types. First, although AP-1s were required for activation of FiRE in both cell types, the binding of AP-1 to FiRE was increased by growth factor-stimulation only in fibroblasts and not in keratinocytes. Secondly, FiRE did not bind FIN-1 nor needed the FIN-1 binding site for EGF-stimulated activation in keratinocytes, in contrast to the FGF-stimulated activation of FiRE in fibroblasts. Thirdly, EGF, which did not activate FiRE in fibroblasts, failed to activate FIN-1 in these cells. Finally, an USF-1 binding site that was necessary for activation of FiRE in keratinocytes was not needed in fibroblasts. These data suggest mechanisms by which members of the EGF- and FGF-families can differentially stimulate transcription through AP-1 regulated elements in a cell type-specific manner.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771971     DOI: 10.1038/sj.onc.1202002

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Involvement of protein kinase A in fibroblast growth factor-2-activated transcription.

Authors:  J P Pursiheimo; M Jalkanen; K Taskén; P Jaakkola
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 2.  Syndecans in cartilage breakdown and synovial inflammation.

Authors:  Thomas Pap; Jessica Bertrand
Journal:  Nat Rev Rheumatol       Date:  2012-10-23       Impact factor: 20.543

3.  Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism.

Authors:  Jedrzej Małecki; Jørgen Wesche; Camilla Skiple Skjerpen; Antoni Wiedłocha; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

4.  Effect of treatment of larynx and hypopharynx carcinomas on serum syndecan-1 concentrations.

Authors:  A Anttonen; S Leppä; P Heikkilä; R Grenman; H Joensuu
Journal:  J Cancer Res Clin Oncol       Date:  2006-03-24       Impact factor: 4.553

Review 5.  Spatiotemporal diversity and regulation of glycosaminoglycans in cell homeostasis and human disease.

Authors:  Amrita Basu; Neil G Patel; Elijah D Nicholson; Ryan J Weiss
Journal:  Am J Physiol Cell Physiol       Date:  2022-03-16       Impact factor: 5.282

6.  Upregulation of LAMB1 via ERK/c-Jun Axis Promotes Gastric Cancer Growth and Motility.

Authors:  Hana Lee; Won-Jin Kim; Hyeon-Gu Kang; Jun-Ho Jang; Il Ju Choi; Kyung-Hee Chun; Seok-Jun Kim
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

7.  Syndecan promotes axon regeneration by stabilizing growth cone migration.

Authors:  Tyson J Edwards; Marc Hammarlund
Journal:  Cell Rep       Date:  2014-07-04       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.